Monitoring Fatigue In Daily Life In Adults With Cerebral Palsy or Acquired Brain Injury

NCT07135791 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-08-22

No results posted yet for this study

Summary

The goal of this observational study is to learn about levels and patterns of fatigue in adults with cerebral palsy (CP) and acquired brain injury (ABI) in daily life.

The main question it aims to answer is: How do adults with CP and ABI experience fatigue in daily life?

Researchers will compare data from CP and ABI with healthy volunteers to see if they experience fatigue differently.

Participants will:

* Monitor their symptoms, mood, and behavior in real-time by completing a brief survey on their mobile phone 10 times a day for seven consecutive days.
* Attend a briefing session the day prior to the seven-day period of real-time monitoring.
* Wear an accelerometer for the seven-day period.
* Complete a daily sleep diary for the seven-day period.
* Receive feedback on their real-time monitoring data, sleep and activity data.

Conditions

  • Fatigue Symptom
  • Fatigue Intensity
  • Cerebral Palsy (CP)
  • Acquired Brain Injury Including Stroke
  • Fatigue, Mental
  • Fatigue

Interventions

DIAGNOSTIC_TEST

Real-time monitoring

Complete a brief 20-item survey 10 times a day for seven consecutive days, while wearing an accelerometer and completing daily sleep diaries.

Sponsors & Collaborators

  • Center for Rehabilitation of Brain Injury (Center for Hjerneskade)

    collaborator UNKNOWN
  • Vejlefjord Rehabilitation

    collaborator OTHER
  • Elsass Foundation

    collaborator OTHER
  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Anne Norup, Ph.D. · Neurorehabilitation Research and Knowledge Centre, Rigshospitalet

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-26
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07135791 on ClinicalTrials.gov